Wegovy 1.0 mg (Semaglutide) Injection

Description

Reach the clinical maintenance level of your weight loss journey with the Wegovy 1.0 mg Pen, designed for Weeks 9 to 12 in the semaglutide titration plan. This is the standard therapeutic dose shown in clinical trials to deliver powerful appetite suppression and meaningful weight loss in adults with obesity or overweight conditions.

💊 Key Features of Wegovy 1.0 mg

• Intermediate therapeutic dose

• Effective for appetite and portion control

• Helps support steady, safe weight loss

• May improve glycemic control in overweight individuals

• Easy-to-use weekly injection

📦 What’s Included

• 1 pen pre-filled with 1.0 mg of semaglutide

• Detailed instructions for home use

• Secure pen cap and dispensing mechanism

🌟 Why 1.0 mg Matters

• Reaches the therapeutic dose used in long-term studies

• May lead to greater fat loss, particularly when combined with lifestyle changes

• Enhances satiety signals, helping you eat less without feeling deprived

• May improve cardiometabolic health markers over time

• Sets the stage for possible transition to 1.7 mg or 2.4 mg for further results

🩺 How to Use

• Administer once per week, same day and time

• Inject under the skin (subcutaneous) in the stomach, thigh, or upper arm

• Rotate injection sites weekly

• Never mix doses or change the schedule without medical approval

⚠️ Important Safety Info

• Indicated for chronic weight management in adults with a BMI ≥30, or ≥27 with related health risks

• Do not use if you or a family member has a history of medullary thyroid carcinoma or MEN 2

• Common side effects: nausea, diarrhea, vomiting, stomach pain, constipation

• Use caution if combining with insulin or sulfonylureas—may increase risk of hypoglycemia

• Avoid during pregnancy or breastfeeding—consult your doctor

❄️ Storage & Handling

• Store unopened pens in the refrigerator: 2°C to 8°C (36°F to 46°F)

• Once opened, pens can be kept at room temperature (up to 30°C / 86°F) for up to 28 days

• Do not freeze. Discard if accidentally frozen

• Protect from sunlight and store in original carton when not in use

❓ Frequently Asked Questions

Q: Is 1.0 mg the final dose of Wegovy?
A: For many, yes. However, your provider may recommend increasing to 1.7 mg or 2.4 mg for greater weight loss depending on your progress.

Q: What results can I expect at 1.0 mg?
A: Most users report consistent appetite suppression and steady weight loss, especially when paired with healthy eating and physical activity.

Q: What if I feel strong side effects at this dose?
A: If symptoms are severe or persistent, consult your provider. Some people stay longer on 0.5 mg or alternate dosing before progressing.

Q: Can I stay on 1.0 mg indefinitely?
A: Yes—this is a clinically effective dose for many patients and may be maintained long-term under medical supervision.

Q: Who should not take Wegovy?
A: You should not use this medicine if you are allergic to it or if you have: multiple endocrine neoplasia type 2 (tumors in your glands); a personal or family history of medullary thyroid carcinoma (a type of thyroid cancer); or diabetic ketoacidosis (call your doctor for treatment). Read about it here.

Q: Is Wegovy better at weight loss than Ozempic?
A: Ozempic has not been directly compared with Wegovy for helping with weight loss. However, based on a review of studies, Wegovy may lead to more weight loss than Ozempic. This is likely because doctors typically prescribe Wegovy at a higher maintenance (long-term) dosage than Ozempic.